Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection.

BACKGROUND Despite considerable evolution in the quality of laboratory-based testing for detection of HCV, the availability of rapid, point-of-care tests may increase diagnoses by increasing opportunities for testing outside of traditional laboratory settings. OBJECTIVES We evaluated the performance of a new, rapid HCV test that can be used with venous blood, finger stick blood, serum, plasma, or oral fluid and compared it to FDA-approved laboratory methods. STUDY DESIGN HCV positive subjects as well as subjects at low risk for HCV were tested with the rapid test using all 5 specimen types and results compared to FDA-approved laboratory methods. In addition, performance was assessed in commercially available seroconversion panels. RESULTS Sensitivity and specificity of the rapid test was equivalent to laboratory EIA and performance was comparable across all 5 specimen types. CONCLUSIONS The OraQuick HCV Rapid Antibody Test appears suitable as an aid in the diagnosis of HCV infection.

[1]  M. Busch,et al.  Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay , 1992, Transfusion.

[2]  A. Wasley,et al.  Surveillance for acute viral hepatitis - United States, 2007. , 2009, Morbidity and mortality weekly report. Surveillance summaries.

[3]  B. Kuehn.  Silent epidemic of viral hepatitis may lead to boom in serious liver disease. , 2009, JAMA.

[4]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[5]  J. McHutchison,et al.  Review article: investigational agents for chronic hepatitis C , 2009, Alimentary pharmacology & therapeutics.

[6]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[7]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[8]  A. Wasley,et al.  Surveillance for acute viral hepatitis--United States, 2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.

[9]  S. Giampaoli,et al.  Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population , 2002, Gut.

[10]  R. Booth,et al.  The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. , 2002, Addiction.

[11]  M. Ullmann,et al.  Evaluation of three commercially available hepatitis C virus antibody detection assays under the conditions of a clinical virology laboratory. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  B. Branson,et al.  Detecting Unsuspected HIV Infection With a Rapid Whole-Blood HIV Test in an Urban Emergency Department , 2007, Journal of acquired immune deficiency syndromes.

[13]  S. Lee,et al.  Improved Detection of Anti‐HCV in Post‐Transfusion Hepatitis by a Third‐Generation ELISA , 1995, Vox sanguinis.

[14]  C P Price,et al.  Point of Care Testing , 1999, BMJ : British Medical Journal.

[15]  M. Bronner,et al.  Histological and clinical outcome after liver transplantation for hepatitis C. , 1998, Hepatology.

[16]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[17]  R. Dinello,et al.  Increased detection of hepatitis C virus infection in commercial plasma donors by a third‐generation screening assay , 1995, Transfusion.

[18]  H. Myrmel,et al.  Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[19]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[20]  S. Stramer,et al.  Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population , 2002, Transfusion.

[21]  L. Finelli,et al.  Surveillance for acute viral hepatitis--United States, 2005. , 2007, Morbidity and mortality weekly report. Surveillance summaries.

[22]  G. Davis,et al.  Projecting future complications of chronic hepatitis C in the United States , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  O. Grusky,et al.  Outcomes of blood and oral fluid rapid HIV testing: a literature review, 2000-2006. , 2007, AIDS patient care and STDs.

[24]  M. Bissell.  Detection of HIV-1 and HCV Infections Among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing , 2006 .